全文获取类型
收费全文 | 71644篇 |
免费 | 6041篇 |
国内免费 | 2721篇 |
专业分类
耳鼻咽喉 | 1303篇 |
儿科学 | 1655篇 |
妇产科学 | 1229篇 |
基础医学 | 8227篇 |
口腔科学 | 2395篇 |
临床医学 | 6462篇 |
内科学 | 6401篇 |
皮肤病学 | 1001篇 |
神经病学 | 2646篇 |
特种医学 | 3859篇 |
外国民族医学 | 54篇 |
外科学 | 8756篇 |
综合类 | 11791篇 |
现状与发展 | 20篇 |
预防医学 | 1825篇 |
眼科学 | 1231篇 |
药学 | 4804篇 |
49篇 | |
中国医学 | 2135篇 |
肿瘤学 | 14563篇 |
出版年
2024年 | 131篇 |
2023年 | 975篇 |
2022年 | 1658篇 |
2021年 | 2967篇 |
2020年 | 2401篇 |
2019年 | 2182篇 |
2018年 | 2071篇 |
2017年 | 2311篇 |
2016年 | 2562篇 |
2015年 | 2767篇 |
2014年 | 4281篇 |
2013年 | 4334篇 |
2012年 | 3927篇 |
2011年 | 4300篇 |
2010年 | 3591篇 |
2009年 | 3583篇 |
2008年 | 3599篇 |
2007年 | 3833篇 |
2006年 | 3476篇 |
2005年 | 3089篇 |
2004年 | 2692篇 |
2003年 | 2300篇 |
2002年 | 2096篇 |
2001年 | 1906篇 |
2000年 | 1575篇 |
1999年 | 1471篇 |
1998年 | 1262篇 |
1997年 | 1191篇 |
1996年 | 1055篇 |
1995年 | 928篇 |
1994年 | 792篇 |
1993年 | 657篇 |
1992年 | 547篇 |
1991年 | 482篇 |
1990年 | 379篇 |
1989年 | 386篇 |
1988年 | 349篇 |
1987年 | 290篇 |
1986年 | 248篇 |
1985年 | 294篇 |
1984年 | 282篇 |
1983年 | 155篇 |
1982年 | 217篇 |
1981年 | 196篇 |
1980年 | 151篇 |
1979年 | 127篇 |
1978年 | 101篇 |
1977年 | 71篇 |
1976年 | 65篇 |
1975年 | 36篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
影像学引导消融治疗已逐渐成为治疗不可切除实体肿瘤的重要方式,但消融治疗后存在肿瘤局部复发及全身转移风险。免疫治疗可通过增强机体自身免疫细胞功能间接清除肿瘤细胞,但多数实体肿瘤对免疫治疗的反应率较低。近年来,基于纳米材料的肿瘤消融技术发展迅速,为增强局部消融效果及提高系统免疫应答提供了新的可能。本文对基于纳米材料的消融联合免疫治疗肿瘤研究进展进行综述。 相似文献
993.
目的探讨改良菱形皮瓣修复面部缺损的临床疗效。方法自2016年1月至2019年12月深圳建安医疗美容门诊部采用改良菱形皮瓣修复面部肿物切除后皮肤软组织缺损患者45例,肿物主要位于耳部、下睑缘、鼻背部、上唇及面颊部;缺损面积为1.5 cm×2.0 cm~3.0 cm×4.0 cm。结果所有患者皮瓣全部成活,切口一期愈合,术后随访6~12个月,术后皮瓣色泽、血运良好,触感正常,外观较满意,且无明显瘢痕。结论采用改良菱形皮瓣修复面部肿物切除后软组织缺损,具有设计灵活、充分利用周围组织、手术操作简单、术后瘢痕较小等优点,值得临床推广。 相似文献
994.
肝细胞癌合并胆管癌栓是肝癌的一种特殊类型,发生率为0.5%~2.5%,疾病进展快、预后差,目前国内外尚无相关的诊断与治疗共识,造成该疾病的治疗极不规范。中国医师协会肝癌专业委员会基于国内外本领域研究获得的循证医学证据,并结合我国临床实践,制订《肝细胞癌合并胆管癌栓多学科诊治中国专家共识(2020版)》。该共识针对肝细胞癌合并胆管癌栓的临床表现、诊断及分型、外科治疗、辅助治疗以及其他局部、区域性和系统性治疗进行系统阐述,旨在规范、普及和提高对肝细胞癌合并胆管癌栓的诊断和多学科治疗水平,改善该疾病总体预后。 相似文献
995.
目的探讨内镜下黏膜切除术(endoscopic mucosal resection,EMR)治疗直径≤10 mm胃肠道神经内分泌瘤(gastrointestinal neuroendocrine tumors,GI-NETs)的安全性和可靠性。方法对烟台市烟台山医院2015年2月至2019年6月40例行EMR治疗直径≤10 mm GI-NETs进行回顾性分析,评价EMR手术的安全性和可靠性。结果 40例均在内镜下以EMR术式完成,整块切除率和RO切除率达到100%,病变均局限于黏膜下层,未浸润固有肌层。术后病理分级:NET 1级(G1)35例,NET 2级(G2)5例,无NET3级(G3)病例。术中术后均无出血、穿孔等并发症。随访:1例失访,1例因其他疾病死亡,其余38例平均随访27.8个月,范围为5~46个月,均无局部复发和远处转移。结论对于分化良好的G1、G2期的直径≤10 mm GI-NETs,EMR是一种安全可靠的治疗手段。 相似文献
996.
997.
Lisa M. Rooper Lester D. R. Thompson Jeffrey Gagan Bahram R. Oliai Ilan Weinreb Justin A. Bishop 《Head and neck pathology》2021,15(1):179
Intraductal carcinoma (IDC) is a rare salivary gland tumor that is considered analogous to ductal carcinoma in-situ of the breast, demonstrating a complex neoplastic epithelial proliferation surrounded by a continuous layer of presumed non-neoplastic myoepithelial cells. It is subcategorized into intercalated duct, apocrine, and hybrid subtypes based on morphologic and immunohistochemical features, with frequent NCOA4-RET and TRIM27-RET fusions, respectively, seen in intercalated duct and hybrid tumors. However, as an expanding clinicopathologic spectrum of IDC has been documented, controversy has emerged as to whether this tumor type is best defined by its intraductal growth pattern or distinctive molecular and immunophenotypic differentiation. Here, we further explore the nature of IDC by evaluating four cases that arose within intraparotid lymph nodes. These intercalated-duct phenotype tumors with diffuse S100 protein expression demonstrated a crowded and complex epithelial proliferation arranged in cystic, cribriform, and micropapillary architecture, surrounded by an intact myoepithelial cell layer, and were completely intranodal. Of two tumors with tissue available for molecular analysis, one demonstrated a NCOA4-RET fusion and one harbored a STRN-ALK fusion that is novel to IDC. Not only does the intranodal presence of IDC present a challenging differential diagnosis, but the complex nature of this proliferation within lymph node tissue raises questions as to whether the myoepithelial component of IDC is actually non-neoplastic in nature. Furthermore, identification of a STRN-ALK fusion expands the genetic spectrum of IDC and adds to evidence of an emerging role for ALK in salivary gland tumors. Further attention to the nature of the myoepithelial cells and documentation of alternate fusion events in IDC may inform continued discussion about its appropriate classification. 相似文献
998.
Abbas Agaimy Robert Stoehr Lars Tgel Arndt Hartmann Thomas Cramer 《Head and neck pathology》2021,15(1):361
Porocarcinoma (synonym: malignant eccrine poroma) is a rare aggressive carcinoma type with terminal sweat gland duct differentiation. The squamous variant of porocarcinoma is even less frequent and might be indistinguishable from conventional squamous cell carcinoma (SCC). We herein describe the first case of a carcinoma presenting as a primary parotid gland malignancy in a 24-year-old male without any other primary tumor. Total parotidectomy and neck dissection were performed followed by adjuvant chemoradiation. The patient remained alive and well 10 months after diagnosis. Histology showed keratinizing SCC infiltrating extensively the parotid gland with subtle poroid cell features. Oncogenic HPV infection was excluded by DNA-based testing. NGS analysis using the TruSight RNA fusion panel (Illumina) revealed a novel YAP1-MAML2 gene fusion. This gene fusion was reported recently in a subset of cutaneous porocarcinoma and poroma. This case of poroid SCC (or squamoid porocarcinoma) adds to the differential diagnosis of SCC presenting as parotid gland tumor and highlights the value of molecular testing in cases with unusual presentation.Electronic supplementary materialThe online version of this article (10.1007/s12105-020-01181-9) contains supplementary material, which is available to authorized users. 相似文献
999.
Justin Bubola Klieb Hagen Nick Blanas Ilan Weinreb Brendan C. Dickson Tra Truong 《Head and neck pathology》2021,15(1):319
Ectomesenchymal chondromyxoid tumor is a rare neoplasm of uncertain histogenesis that typically occurs in the anterior dorsal tongue. Recent reports in the literature have described rare examples of gingival, palatal and tonsillar lesions. Histologically, ectomesenchymal chondromyxoid tumors are typically well-circumscribed, lacking overtly aggressive features. Herein we report a tumor arising in the right mandible that is morphologically and molecularly consistent with ectomesenchymal chondromyxoid tumor. This case furthers awareness of the extra-glossal distribution of this neoplasm; moreover, it suggests that a subset of these tumors have the potential for locally aggressive behaviour.Electronic supplementary materialThe online version of this article (10.1007/s12105-020-01169-5) contains supplementary material, which is available to authorized users. 相似文献
1000.
Michel Ribeiro Fernandes Caroline Lorenzoni Almeida Ghezzi Tomaz JM Grezzana-Filho Fl via Heinz Feier Ian Leipnitz Aljamir Duarte Chedid Carlos Thadeu Schmidt Cerski Marcio Fernandes Chedid Cl ber Rosito Pinto Kruel 《World journal of gastrointestinal surgery》2021,13(3):315-322
BACKGROUNDPrimary extra-gastrointestinal stromal tumors (E-GIST) of the liver are rare. The clinical presentation may range from asymptomatic to bleeding or manifestations of mass effect. Oncologic surgery followed by adjuvant therapy with imatinib is the standard of care. However, under specific circumstances, a cytoreductive approach may represent a therapeutic option. We describe herein the case of an 84-year-old woman who presented with a tender, protruding epigastric mass. Abdominal computed tomography scan revealed a large, heterogeneous mass located across segments III, IV, V, and VIII of the liver. The initial approach was transarterial embolization of the tumor, which elicited no appreciable response. Considering the large size and central location of the tumor and the advanced age of the patient, non-anatomic complete resection was indicated. Due to substantial intraoperative bleeding and hemodynamic instability, only a near-complete resection could be achieved. Histopathology and immunohistochemical staining confirmed the diagnosis of primary E-GIST of the liver. Considering the risk/benefit ratio for therapeutic options, debulking surgery may represent a strategy to control pain and prolong survival.CASE SUMMARYHere, we present a case report of a patient diagnosed with E-GIST primary of the liver, which was indicated a cytoreductive surgery and adjuvant therapy with imatinib.CONCLUSIONE-GIST primary of the liver is a rare conditional, the treatment is with systemic therapy and total resection surgery. However, a cytoreductive surgery will be necessary when a complete resection is no possible. 相似文献